Act on PAH webinar: 'Early diagnosis of PAH in scleroderma–spectrum disorders'
We are pleased to have welcomed Dr John D Pauling and Dr Dan Knight to host the first Act on PAH webinar on the 20th November 2019, titled, ‘Early diagnosis of PAH in scleroderma–spectrum disorders'. Please view a recording below.
Dr Pauling began the webinar with his presentation, ‘Risk factors and benefits of early diagnosis’, highlighting the poor prognosis of SSc–PAH compared with idiopathic PAH and exploring his personal and practical approach to screening. Dr Knight followed with his presentation, ‘Screening strategies for PAH in systemic sclerosis’, exploring the reasoning behind screening patients for PAH, how to use DETECT and tackling the issue of when to refer.
Both presentations were followed by a lively Q&A session, in which the audience submitted questions relating to topics such as managing borderline scleroderma patients with PAH and further information regarding the use of the DETECT algorithm.